» Articles » PMID: 31599065

Modest Rates and Wide Variation in Timely Access to Repeat Kidney Transplantation in the United States

Overview
Journal Am J Transplant
Publisher Elsevier
Specialty General Surgery
Date 2019 Oct 11
PMID 31599065
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Success of transplantation is not limited to initial receipt of a donor organ. Many kidney transplant recipients experience graft loss following initial transplantation and the benefits of expedited placement on the waiting list and retransplantation extend to this population. Factors associated with access to repeat transplantation may be unique given experience with the transplant process and prior viability as a candidate. We examined the incidence, risk factors, secular changes, and center-level variation of preemptive relisting or transplantation (PRLT) for kidney transplant recipients in the United States with graft failure (not due to death) using Scientific Registry of Transplant Recipients data from 2007 to 2018 (n = 39 557). Overall incidence of PRLT was 15% and rates of relisting declined over time. Significantly lower PRLT was evident among patients who were African American and Hispanic, males, older, obese, publicly insured, had lower educational attainment, were diabetic, had longer dialysis time prior to initial transplant, shorter graft survival, longer distance to transplant center, and resided in distressed communities. There was significant variation in PRLT by center, median = 13%, 10th percentile = 6%, 90th percentile = 24%. Cumulatively, results indicate that despite prior access to transplantation, incidence of PRLT is modest with pronounced clinical, social, and center-level sources of variation suggesting opportunities to improve preemptive care among patients with failing grafts.

Citing Articles

Push toward pre-emptive kidney transplantation - for sure?.

Cseprekal O, Jacquelinet C, Massy Z Clin Kidney J. 2024; 17(12):sfae335.

PMID: 39698373 PMC: 11653007. DOI: 10.1093/ckj/sfae335.


Differences in Racial and Ethnic Disparities Between First and Repeat Kidney Transplantation.

Sandal S, Ahn J, Chen Y, Thompson V, Purnell T, Cantarovich M Transplantation. 2024; 108(10):2144-2152.

PMID: 38771099 PMC: 11424272. DOI: 10.1097/TP.0000000000005051.


Clinical relevance of HLA-DQ eplet mismatch and maintenance immunosuppression with risk of allosensitization after kidney transplant failure.

Tran J, Alrajhi I, Chang D, Sherwood K, Keown P, Gill J Front Genet. 2024; 15:1383220.

PMID: 38638120 PMC: 11024336. DOI: 10.3389/fgene.2024.1383220.


Impact of Calcineurin Inhibitor-Based Immunosuppression Maintenance During the Dialysis Period After Kidney Transplant Failure on the Next Kidney Graft Outcome: A Retrospective Multicenter Study With Propensity Score Analysis.

Noelle J, Mayet V, Lambert C, Couzi L, Chauveau B, Thierry A Transpl Int. 2023; 36:11775.

PMID: 37799669 PMC: 10548547. DOI: 10.3389/ti.2023.11775.


Conservative Kidney Management in Kidney Transplant Populations.

Murakami N, Reich A, Pavlakis M, Lakin J Semin Nephrol. 2023; 43(1):151401.

PMID: 37499572 PMC: 10543459. DOI: 10.1016/j.semnephrol.2023.151401.


References
1.
Weinhandl E, Snyder J, Israni A, Kasiske B . Effect of comorbidity adjustment on CMS criteria for kidney transplant center performance. Am J Transplant. 2009; 9(3):506-16. PMC: 2670063. DOI: 10.1111/j.1600-6143.2008.02527.x. View

2.
Heaphy E, Poggio E, Flechner S, Goldfarb D, Askar M, Fatica R . Risk factors for retransplant kidney recipients: relisting and outcomes from patients' primary transplant. Am J Transplant. 2014; 14(6):1356-67. DOI: 10.1111/ajt.12690. View

3.
Axelrod D, Guidinger M, Finlayson S, Schaubel D, Goodman D, Chobanian M . Rates of solid-organ wait-listing, transplantation, and survival among residents of rural and urban areas. JAMA. 2008; 299(2):202-7. DOI: 10.1001/jama.2007.50. View

4.
Hickson L, Hickson L, El-Zoghby Z, Lorenz E, Stegall M, Jaffe A . Patient survival after kidney transplantation: relationship to pretransplant cardiac troponin T levels. Am J Transplant. 2009; 9(6):1354-61. DOI: 10.1111/j.1600-6143.2009.02636.x. View

5.
Carrero J, Hecking M, Chesnaye N, Jager K . Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018; 14(3):151-164. DOI: 10.1038/nrneph.2017.181. View